Search

Article Information


The Other Drug War: U.S.-Japan Trade in Pharmaceuticals
Yoshikawa, Aki
31/2  (Winter 1989): 76-90

The Japanese pharmaceutical market is the second largest in the world, worth about $26 billion in 1985. The industry is one of the few high-technology areas in which the United States still maintains a favorable balance of trade with Japan. Today, the Japanese pharmaceutical market is experiencing a major structural reorganization as a result of both scientific breakthroughs in the development of biotechnology and government measures to liberalize trade under pressure from abroad. This reorganization process will provide many new opportunities for American and other foreign firms, but it will also bring them new challenges from increasingly competitive and internationally oriented Japanese drug companies.

 

California Management Review

Berkeley-Haas's Premier Management Journal

Published at the University of California for more than sixty years, California Management Review seeks to share knowledge that challenges convention and shows a better way of doing business.

Learn more
Follow Us